Drawing for NESTEXA

USPTO serial 77928138

NESTEXA

Reviewed by CopyMark Law Group

Reg. 3910115Status 710
Filing date
Status date
Registration date
Jan 25, 2011
Examiner
MCBRIDE, THEODORE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with NESTEXA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Hanes

Christopher M. Hanes GLAXOSMITHKLINEFive Moore DriveLegal Global Trademarks, Mailstop: 5.5AResearch Triangle Park, NC 27709-0183

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccinesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 2017C8..CANCELLED SEC. 8 (6-YR)—
Jan 25, 2016REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 23, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 25, 2013CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 25, 2013COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 25, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 25, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 9, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 9, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 1, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 15, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 15, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 11, 2010ALIEASSIGNED TO LIE—
Aug 27, 2010ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
May 13, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 23, 2010GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 23, 2010GNSLLETTER OF SUSPENSION E-MAILED—
Apr 23, 2010CNSLSUSPENSION LETTER WRITTEN—
Apr 21, 2010DOCKASSIGNED TO EXAMINER—
Feb 12, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 8, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance